hydroxyurea has been researched along with Pneumonia in 16 studies
Pneumonia: Infection of the lung often accompanied by inflammation.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To analyze the results of idarubicin (IDA)- versus etoposide (VP16)-intensified myeloablative conditioning regimen in allogeneic hematopoietic stem cell transplantation (allo-SCT) for high-risk acute leukemia." | 7.75 | A comparative study of outcomes of idarubicin- and etoposide-intensified conditioning regimens for allogeneic peripheral blood stem cell transplantation in patients with high-risk acute leukemia. ( Chen, ZC; Li, L; Li, QB; Xia, LH; You, Y; Zou, P, 2009) |
| "Hydroxyurea is an antimetabolite drug used in the treatment of myeloproliferative disorders." | 5.40 | [Hydroxyurea-induced pneumonia]. ( Claeyssen, V; Decaux, O; Delaval, P; Desrues, B; Girard, A; Jouneau, S; Poullot, E; Ricordel, C, 2014) |
| "To analyze the results of idarubicin (IDA)- versus etoposide (VP16)-intensified myeloablative conditioning regimen in allogeneic hematopoietic stem cell transplantation (allo-SCT) for high-risk acute leukemia." | 3.75 | A comparative study of outcomes of idarubicin- and etoposide-intensified conditioning regimens for allogeneic peripheral blood stem cell transplantation in patients with high-risk acute leukemia. ( Chen, ZC; Li, L; Li, QB; Xia, LH; You, Y; Zou, P, 2009) |
| "Hydroxyurea is increasingly being used to control myeloproliferative disorders, in part because of its relative lack of side effects." | 3.68 | Acute alveolitis induced by hydroxyurea in a patient with myeloproliferative syndrome. ( Andreesen, R; Bross, KJ; Hennemann, B; Reichle, A, 1993) |
| "Treatment with zileuton altered the inflammatory response after antigen challenge." | 2.68 | A controlled trial of the effect of the 5-lipoxygenase inhibitor, zileuton, on lung inflammation produced by segmental antigen challenge in human beings. ( Cohn, J; Dworski, RT; Fish, JE; Kane, GC; Kim, CJ; Murray, JJ; Peters, SP; Pollice, M; Sheller, JR, 1996) |
| "The clinical course suggests that the pneumonitis was induced by hydroxycarbamide." | 2.58 | A 66-year-old man with hydroxycarbamide induced pneumonitis. ( Derichs, C; Klooster, P; Vlasveld, LT, 2018) |
| "Hydroxyurea is an antimetabolite drug used in the treatment of myeloproliferative disorders." | 1.40 | [Hydroxyurea-induced pneumonia]. ( Claeyssen, V; Decaux, O; Delaval, P; Desrues, B; Girard, A; Jouneau, S; Poullot, E; Ricordel, C, 2014) |
| " However, no epidemiologic information about the occurrence of the most clinically significant HU-associated adverse events is yet available." | 1.38 | Hydroxyurea-related toxicity in 3,411 patients with Ph'-negative MPN. ( Antonioli, E; Baccarani, M; Barbui, T; Bertozzi, I; Bosi, A; Cacciola, E; Cacciola, R; Cazzola, M; De Stefano, V; Elli, E; Finazzi, G; Finazzi, M; Guglielmelli, P; Luigia Randi, M; Martinelli, V; Passamonti, F; Pieri, L; Pogliani, E; Rambaldi, A; Rodeghiero, F; Rossi, E; Ruggeri, M; Rumi, E; Vannucchi, AM; Vianelli, N; Za, T, 2012) |
| "Hydroxyurea (HU) is a good-controllable and well-tolerated cytostatic drug." | 1.32 | [Hydroxyurea-induced pneumonitis]. ( Schwonzen, M; Spangenberger, H; Spengler, M, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (25.00) | 18.7374 |
| 1990's | 3 (18.75) | 18.2507 |
| 2000's | 5 (31.25) | 29.6817 |
| 2010's | 4 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Derichs, C | 1 |
| Klooster, P | 1 |
| Vlasveld, LT | 1 |
| Girard, A | 1 |
| Ricordel, C | 1 |
| Poullot, E | 1 |
| Claeyssen, V | 1 |
| Decaux, O | 1 |
| Desrues, B | 1 |
| Delaval, P | 1 |
| Jouneau, S | 1 |
| Loo, PS | 1 |
| Khan, M | 1 |
| Currie, GP | 1 |
| Husain, E | 1 |
| Kerr, KM | 1 |
| Li, QB | 1 |
| Li, L | 1 |
| You, Y | 1 |
| Chen, ZC | 1 |
| Xia, LH | 1 |
| Zou, P | 1 |
| Carmel, R | 1 |
| Bellevue, R | 1 |
| Kelman, Z | 1 |
| Antonioli, E | 1 |
| Guglielmelli, P | 1 |
| Pieri, L | 1 |
| Finazzi, M | 1 |
| Rumi, E | 1 |
| Martinelli, V | 1 |
| Vianelli, N | 1 |
| Luigia Randi, M | 1 |
| Bertozzi, I | 1 |
| De Stefano, V | 1 |
| Za, T | 1 |
| Rossi, E | 1 |
| Ruggeri, M | 1 |
| Elli, E | 1 |
| Cacciola, R | 1 |
| Cacciola, E | 2 |
| Pogliani, E | 1 |
| Rodeghiero, F | 1 |
| Baccarani, M | 2 |
| Passamonti, F | 1 |
| Finazzi, G | 1 |
| Rambaldi, A | 1 |
| Bosi, A | 1 |
| Cazzola, M | 1 |
| Barbui, T | 1 |
| Vannucchi, AM | 1 |
| Schwonzen, M | 1 |
| Spangenberger, H | 1 |
| Spengler, M | 1 |
| Wong, CC | 1 |
| Brown, D | 1 |
| Howling, SJ | 1 |
| Parker, NE | 1 |
| Radaelli, F | 1 |
| Bramanti, S | 1 |
| Fantini, NN | 1 |
| Fabio, G | 1 |
| Greco, I | 1 |
| Lambertenghi-Deliliers, G | 1 |
| Snapper, JR | 1 |
| Brigham, KL | 1 |
| Hennemann, B | 1 |
| Bross, KJ | 1 |
| Reichle, A | 1 |
| Andreesen, R | 1 |
| Kane, GC | 1 |
| Pollice, M | 1 |
| Kim, CJ | 1 |
| Cohn, J | 1 |
| Dworski, RT | 1 |
| Murray, JJ | 1 |
| Sheller, JR | 1 |
| Fish, JE | 1 |
| Peters, SP | 1 |
| Bell, RL | 1 |
| Harris, RR | 1 |
| Malo, PE | 1 |
| Bouska, JB | 1 |
| Shaughnessy, TK | 1 |
| Hulkower, KI | 1 |
| Brooks, CD | 1 |
| Carter, GW | 1 |
| Slocombe, RF | 1 |
| Malark, J | 1 |
| Ingersoll, R | 1 |
| Derksen, FJ | 1 |
| Robinson, NE | 1 |
| Tura, S | 1 |
| Mandelli, F | 1 |
| Amadori, S | 1 |
| Cajozzo, A | 1 |
| di Marco, P | 1 |
| Panzacchi, G | 1 |
| Musso, R | 1 |
| Alberti, A | 1 |
| Magro, S | 1 |
| Rossi Ferrini, P | 1 |
| Leoni, F | 1 |
| Salti, F | 1 |
| Basetta, E | 1 |
| Monfardini, S | 1 |
| Buonanno, G | 1 |
| Rizzoli, V | 1 |
| Carnevali, C | 1 |
| Lucarelli, G | 1 |
| Porcellini, A | 1 |
| Torlontano, G | 1 |
| Fioritoni, G | 1 |
| Yamada, S | 1 |
| Perot, PL | 1 |
| Ducker, TB | 1 |
| Gale, GR | 1 |
2 reviews available for hydroxyurea and Pneumonia
| Article | Year |
|---|---|
A 66-year-old man with hydroxycarbamide induced pneumonitis.
Topics: Administration, Oral; Aged; Disease Progression; Dose-Response Relationship, Drug; Drug Administrati | 2018 |
Inflammation and airway reactivity.
Topics: Aerosols; Animals; Asthma; Disease Models, Animal; Dogs; Endotoxins; Granulocytes; Guinea Pigs; Hist | 1984 |
1 trial available for hydroxyurea and Pneumonia
| Article | Year |
|---|---|
A controlled trial of the effect of the 5-lipoxygenase inhibitor, zileuton, on lung inflammation produced by segmental antigen challenge in human beings.
Topics: Adult; Antigens; Bronchoalveolar Lavage Fluid; Cell Count; Double-Blind Method; Eosinophils; Female; | 1996 |
13 other studies available for hydroxyurea and Pneumonia
| Article | Year |
|---|---|
[Hydroxyurea-induced pneumonia].
Topics: Aged; Antineoplastic Agents; Female; Humans; Hydroxyurea; Lymphoproliferative Disorders; Pneumonia; | 2014 |
Hydroxycarbamide-induced pneumonitis.
Topics: Enzyme Inhibitors; Female; Follow-Up Studies; Humans; Hydroxyurea; Middle Aged; Pneumonia; Radiograp | 2009 |
A comparative study of outcomes of idarubicin- and etoposide-intensified conditioning regimens for allogeneic peripheral blood stem cell transplantation in patients with high-risk acute leukemia.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Aspergillus; Busulfan; China; Combine | 2009 |
Low cobalamin levels associated with sickle cell disease: Contrasting origins and clinical meanings in two instructive patients.
Topics: Adult; Anemia, Pernicious; Anemia, Sickle Cell; Autoantibodies; Depression; Female; Folic Acid; Gast | 2010 |
Hydroxyurea-related toxicity in 3,411 patients with Ph'-negative MPN.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites; Carcinoma, Squamous Cell; Drug Eruptions; Female; F | 2012 |
[Hydroxyurea-induced pneumonitis].
Topics: Antineoplastic Agents; Diagnosis, Differential; Humans; Hydroxyurea; Male; Middle Aged; Pneumonia; P | 2003 |
Hydroxyurea-induced pneumonitis in a patient with chronic idiopathic myelofibrosis after prolonged drug exposure.
Topics: Diagnosis, Differential; Humans; Hydroxyurea; Male; Middle Aged; Pneumonia; Primary Myelofibrosis | 2003 |
Dasatinib-related alveolar pneumonia responsive to corticosteroids.
Topics: Adrenal Cortex Hormones; Dasatinib; Humans; Hydroxyurea; Lung; Male; Middle Aged; Pleural Effusion; | 2006 |
Acute alveolitis induced by hydroxyurea in a patient with myeloproliferative syndrome.
Topics: Acute Disease; Aged; Alveolitis, Extrinsic Allergic; Humans; Hydroxyurea; Male; Myeloproliferative D | 1993 |
ABT-761 attenuates bronchoconstriction and pulmonary inflammation in rodents.
Topics: Animals; Bronchoconstriction; Enzyme Inhibitors; Eosinophils; Guinea Pigs; Humans; Hydroxyurea; In V | 1997 |
Importance of neutrophils in the pathogenesis of acute pneumonic pasteurellosis in calves.
Topics: Acute Disease; Animals; Cattle; Cattle Diseases; Hydroxyurea; Leukocyte Count; Male; Neutrophils; Pa | 1985 |
Splenectomy in early chronic myeloid leukaemia: preliminary report on 37 cases.
Topics: Adolescent; Adult; Blood Cell Count; Blood Platelets; Cytarabine; Death; Drug Therapy, Combination; | 1974 |
Effect of prolonged continuous intracarotid arterial perfusion of hydroxyurea on the normal monkey brain.
Topics: Animals; Brain; Carotid Arteries; Glioblastoma; Haplorhini; Hydroxyurea; Hypoxia; Macaca; Methods; P | 1974 |